                               SEQUENCE LISTING

<110> LONZA WALKERSVILLE, INC.
      LONZA ISRAEL LTD.
 
<120> ALLOGENEIC T-CELLS AND METHODS FOR PRODUCTION THEREOF

<130> 0132-0081WO1

<140> PCT/US2020/058777
<141> 2020-11-04

<150> 62/930,617
<151> 2019-11-05

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 20
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
ucucucagcu gguacacggc                                                   20


<210> 2
<211> 20
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
cucucagcug guacacggca                                                   20


<210> 3
<211> 20
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
gagaaucaaa aucggugaau                                                   20


<210> 4
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<400> 4
Xaa Ile Gln Asn Pro Asp Pro Ala Val Tyr Gln Leu Arg Asp Ser Lys 
1               5                   10                  15      


Ser Ser Asp Lys Ser Val Cys Leu Phe Thr Asp Phe Asp Ser Gln Thr 
            20                  25                  30          



